|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.056 DKK | -4.76% |
|
+86.67% | +86.67% |
| Mar. 29 | Dancann Pharma Plans Up to DKK19 Million Rights Issue | MT |
| Feb. 28 | DanCann Pharma Notes Cannabis Legalization in Germany as Shares Surge | MT |
Dancann Pharma A/S reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was DKK 1.02 million compared to DKK 1.64 million a year ago. Net loss was DKK 3.53 million compared to DKK 3.18 million a year ago.
Basic loss per share from continuing operations was DKK 0.05.
| 1st Jan change | Capi. | |
|---|---|---|
| +86.67% | 1.34M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.73B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
DANCANN PHARMA A/S 
